A total of 1 recommendations were tracked for Aptus Pharma SME IPO. Out of 1 , 0 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 0 for Avoid and 1 hasn't given any rating. In terms of percentage 0% institutes has rated Aptus Pharma SME IPO for subscribe.
